ZA200703619B - High-dosage extended-release formulation of gepirone - Google Patents

High-dosage extended-release formulation of gepirone

Info

Publication number
ZA200703619B
ZA200703619B ZA200703619A ZA200703619A ZA200703619B ZA 200703619 B ZA200703619 B ZA 200703619B ZA 200703619 A ZA200703619 A ZA 200703619A ZA 200703619 A ZA200703619 A ZA 200703619A ZA 200703619 B ZA200703619 B ZA 200703619B
Authority
ZA
South Africa
Prior art keywords
gepirone
release formulation
dosage extended
dosage
extended
Prior art date
Application number
ZA200703619A
Inventor
Stephen J Kramer
Louis F Fabre
Original Assignee
Fabre Kramer Holdings Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Kramer Holdings Inc filed Critical Fabre Kramer Holdings Inc
Priority to ZA200703619A priority Critical patent/ZA200703619B/en
Publication of ZA200703619B publication Critical patent/ZA200703619B/en

Links

ZA200703619A 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone ZA200703619B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
ZA200703619A ZA200703619B (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA200703619A ZA200703619B (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Publications (1)

Publication Number Publication Date
ZA200703619B true ZA200703619B (en) 2008-08-27

Family

ID=40707385

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200703619A ZA200703619B (en) 2004-11-05 2004-11-05 High-dosage extended-release formulation of gepirone

Country Status (1)

Country Link
ZA (1) ZA200703619B (en)

Similar Documents

Publication Publication Date Title
HK1199874A1 (en) Spiro-oxindole compounds and their uses as therapeutic agents
IL179991A0 (en) Modified release formulation of memantine
IL186615A0 (en) Spiroheterocylic compounds and their uses as therapeutic agents
HK1213814A1 (en) Diclofenac formulations and methods of use
EP1717231A4 (en) Substituted azole compounds and thereof preparation and application
EP1841397A4 (en) Formulations and treatments for trichology
PL1713999T3 (en) Cupboard-type piece of furniture
EP1720888A4 (en) Antimicrobial carbohydrates and methods of using same
ZA200705881B (en) Formulations and treatments for well-being
EP1740541A4 (en) Therapeutic formulations of desoxyepothilones
IL181300A0 (en) Photosensitizer formulations and uses thereof
EP1757282A4 (en) The use of kauranes compounds in the manufacture of medicament
HK1101869A1 (en) Leg body and furniture
EP1809255A4 (en) High-dosage extended-release formulation of gepirone
PL375008A1 (en) New application of epirubicine hydrochloride in medicine
ZA200703619B (en) High-dosage extended-release formulation of gepirone
GB0312844D0 (en) Use of compounds in medicine
IL185548A0 (en) Medical uses of 39-desmethoxyrapamycin and analogues thereof
GB0421767D0 (en) Compounds and their medical uses
GB0421766D0 (en) Compounds and their medical uses
TW579764U (en) Improved structure of leg of table
GB0412882D0 (en) New formulation of eletriptan
IL160203A0 (en) Structure of furniture
TW543409U (en) Structure of leg for furniture
PL114913U1 (en) Furniture leg